Form 4 for ESAB ESAB Corp
Accepted 2025-08-01 00:00:00 ET · period of report 2025-07-31 · accession 0001877322-25-000127 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-01 | 2025-07-31 | ESAB | Biebuyck Olivier | Pres, Fab Tech | S - Sale+OE | $133.49 | -1,440 | 15.0K | -9% | -$192.2K |
| D | 2025-08-01 | 2025-07-31 | ESAB | Biebuyck Olivier | Pres, Fab Tech | F - Tax | $135.68 | -2,973 | 16.4K | -15% | -$403.4K |
| D | 2025-08-01 | 2025-07-31 | ESAB | Biebuyck Olivier | Pres, Fab Tech | M - OptEx | $46.94 | +4,413 | 19.4K | +29% | +$207.1K |
| D | 2025-08-01 | 2025-07-31 | ESAB | Biebuyck Olivier | Pres, Fab Tech | M - OptEx | $0.00 | -4,413 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.001 | 2025-07-31 | S | D | 1,440 | $133.49 | 14,989 | D | — | — | |
| 2 | Common | Common stock, par value $0.001 | 2025-07-31 | F | D | 2,973 | $135.68 | 16,429 | D | — | — | (F1) Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the tax liability and exercise price associated with the reporting person's exercise of employee stock options. No shares were sold by the reporting person to satisfy the exercise price or this tax liability. |
| 3 | Common | Common stock, par value $0.001 | 2025-07-31 | M | A | 4,413 | $46.94 | 19,402 | D | — | — | |
| 4 | Derivative | Employee Stock Option (right to buy) | 2025-07-31 | M | D | 4,413 | $0.00 | 0 | D | $46.94 · 2023-02-24 to 2027-02-23 | 4,413 Common stock, par value $0.001 | (F3) This award represents options that vested in three equal annual installments beginning on the first anniversary of the grant date. 7,334 options were fully vested and exercisable as of the date of ESAB Corporation's separation from Colfax Corporation. All remaining options became fully vested and exercisable on February 24, 2023. |